All Curated Mutation Sites in HBV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All

BCP

Core Promoter

Core Upstream Regulatory Sequence

Keyword: Occult HBV Infection-20799931

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	20799931	T127A	S	S	Occult HBV Infection	G C L	View
2	20799931	A128V	S	S	Occult HBV Infection	G C L	View
3	20799931	G71D	S	S	Occult HBV Infection	G C L	View
4	20799931	L95S	S	S	Occult HBV Infection	G C L	View
5	20799931	M103I	S	S	Occult HBV Infection	G C L	View
6	20799931	P111L	S	S	Occult HBV Infection	G C L	View
7	20799931	S113A	S	S	Occult HBV Infection	G C L	View
8	20799931	S114P	S	S	Occult HBV Infection	G C L	View
9	20799931	S117G	S	S	Occult HBV Infection	G C L	View
10	20799931	T115I	S	S	Occult HBV Infection	G C L	View
11	20799931	T116P	S	S	Occult HBV Infection	G C L	View
12	20799931	T118R	S	S	Occult HBV Infection	G C L	View
13	20799931	T125M	S	S	Occult HBV Infection	G C L	View

Contents
Description

The table shows all curated mutation sites of HBV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.